A Randomized, Open-label, Single Dose, 3-Period, 6-Sequence Cross-Over Trial to Investigate the Relative Bioavailability of Apraglutide Versus the Reference Formulation Following Subcutaneous Administrations.
This research study is about a medicine called apraglutide, which is still being developed. We want to compare how your body uses this medicine when it's given in two slightly different forms. It's like checking if two different brands of the same medication work the same way in your body. We're looking for healthy adults to take part. By understanding how the body absorbs this medicine, we can make sure future patients get the most benefit from it. This is a very early stage study, focusing on how the medicine moves through healthy people's bodies.
At a glance
What is this study about?
This study is about a new medicine called apraglutide. Before any new medicine can be used to treat illnesses, scientists need to understand a lot about how it works in the human body. This particular study is an early step in that process. We're interested in something called 'bioavailability,' which simply means how much of the medicine actually gets into your bloodstream and is available to do its job.
Imagine you take a medicine — only a certain amount of it gets absorbed into your body to start working. In this study, we're comparing two different ways of giving apraglutide to healthy volunteers to see if one way allows more of the medicine to get into the body than the other. This helps us find the best and most effective way to give the medicine once it's ready for patients.
This kind of research, called a 'bioequivalence study,' is really important. It helps us make sure that different versions or ways of giving a medicine are just as effective. For healthy volunteers, it’s a way to contribute to medical science and help future patients who might need this medicine.
Key takeaways
- This study helps understand how a new medicine, apraglutide, works in the body.
- It compares two different ways of giving the medicine.
- It's for healthy adults aged 18 and over, both men and women.
- Participation involves three clinic visits with stays for monitoring.
- You'll be helping medical science for future patients.
Who may be eligible?
To take part in this study, you need to be a healthy adult. This means you generally feel well and don't have any serious ongoing medical conditions or illnesses that might affect how the medicine works in your body.
You should be at least 18 years old. There's no upper age limit, meaning older adults are also welcome to join, as long as they are healthy.
Both men and women can participate in this study. The researchers are looking for a diverse group of healthy individuals to get a good understanding of how the medicine acts in different people.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you generally healthy and feel well?
- Are you 18 years old or older?
- Do you have any serious long-term health conditions?
- Are you able to commit to several clinic visits?
- Are you able to stay at the clinic for monitoring after receiving the medicine?
What does participation involve?
If you decide to take part, you'll be involved for a short period. This study involves three separate visits to the clinic, with some time in between each visit. During each visit, you'll receive a dose of the studymedicine as an injection under the skin (subcutaneous). You'll then stay at the clinic for a period so doctors can take regular blood samples to see how the medicine is moving through your body. There will also be some health checks, like measuring your heart rate and blood pressure, to make sure you're doing well. After each study period, you'll go home before returning for the next one. The total time you'll be involved from your first visit to your last follow-up will be explained to you.
Potential risks and benefits
Locations (1)
- —UnverifiedNetherlands
Common questions
What is 'bioavailability'?
It's how much of the medicine gets into your bloodstream and is available to work in your body.
Why is this study for 'healthy' people?
By studying healthy people, we can see how the medicine works on its own, without other health conditions affecting the results.
Will I be given the same medicine every time?
Yes, you'll receive apraglutide, but in slightly different ways or forms over the three visits to compare how your body reacts.
Do I have to stay at the clinic?
Yes, after each dose, you'll stay at the clinic for a period for monitoring and blood tests, then you can go home.
Will I be paid for taking part?
It's common for healthy volunteer studies to offer some payment for your time and travel, but this would be discussed with you.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.